PCOS and Menopause: What Changes, What Doesn't, What Matters

Women with PCOS — about 1 in 10 women carry the diagnosis (NHS) — spent decades being told their hormones were too loud. And then menopause arrives promising hormonal quiet, and nobody’s quite sure what happens when the two meet. The honest summary: the ovarian noise fades, the metabolic legacy doesn’t, and the transition itself is harder to read on a baseline that was never regular. All three are navigable with the right map.

An unreadable calendar (and one strange tell)

Perimenopause is usually announced by cycles turning irregular — a useless signal when irregular was always your baseline. Two better landmarks for PCOS:

• The symptom cluster, not the calendar. New hot flashes, night sweats, sleep fragmenting, dryness — these announce the transition regardless of cycle history
• The counterintuitive tell: many women with PCOS find cycles becoming more regular in their 40s — as the follicle surplus winds down, ovulation can briefly get more orderly. Regularity arriving after chaotic decades is, oddly, a perimenopause sign for you

Hormone tests, already blunt instruments in perimenopause, are blunter still against a PCOS baseline — pattern-tracking does more work. A dated log of whatever your cycles are doing plus the new symptoms (one tap a day in Cyclora) is the version of the story a clinician can actually read. On timing: studies suggest menopause arrives on average about two years later with PCOS — wide variation, plan nothing around it.

What quiets down — and what doesn’t

The androgen symptoms often ease but rarely vanish. Acne and hair issues may soften as ovarian androgens decline with age — though menopause’s own estrogen-androgen ratio shift partially offsets this, so improvements tend to be gradual rather than dramatic.

The metabolic side is the part that matters now. PCOS’s core engine — insulin resistance (ACOG) — doesn’t retire with the ovaries, and menopause independently worsens insulin sensitivity, shifts cholesterol, and moves fat to the middle. Stacked, they make diabetes and cardiovascular risk the central PCOS issue of midlife — the CDC lists PCOS among the women-specific heart-disease risk factors — displacing the fertility and cosmetic concerns that dominated earlier decades.

Which reorders the priorities: regular HbA1c, blood pressure, and lipid checks (the screening set, taken seriously rather than eventually), strength training and movement as insulin-sensitivity treatment, and Mediterranean-direction eating. All the standard midlife advice — with less optional-ness attached.

One more carried-forward item: years of irregular, infrequent ovulation raise endometrial (womb-lining) risk somewhat, which makes the universal rule extra-binding for you — any bleeding after twelve period-free months gets assessed promptly, and so does a return to months-long gaps followed by very heavy flooding.

When to see a doctor

Book a proper midlife review if your PCOS care faded out in your 30s — this is the decade it becomes cardiology-adjacent, and treatment plans built around fertility deserve rebuilding around metabolism. Book too if menopause symptoms are biting (HRT is an option for most women with PCOS — it’s a worthwhile conversation, not a contraindication), or for the bleeding flags above. PCOS taught you early that your hormones require self-advocacy; menopause is the sequel where that skill pays off.